Nanozyme technology at Moscow State University. Achievements and development perspectives


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The work describes novel functional bionanosystems for treatment and diagnostics on the basis of proteins, enzymes, polymeric coatings, and magnetic nanoparticles developed at Lomonosov Moscow State University Laboratory for Chemical Design of Bionanomaterials in collaboration with scientists from UNC Eshelman School of Pharmacy (USA). The properties of enzymes (superoxide dismutase, catalase, organophosphate hydrolase, and lysines of bacteriophages) and other drug molecules immobilized in polymeric complexes, as well as the methods for targeted drug delivery using cell-mediated systems and magnetic nanoparticles in in vitro and in vivo operating conditions, are discussed. Physical and chemical characteristics, including data on the functional properties of the nanoformulations, are obtained. The nanoformulations developed demonstrated high potential therapeutic efficacy for the treatment of central nervous system and brain diseases, inflammations (including inflammatory diseases of the eye), cancer and infectious diseases, neurotoxic injury, and others. The possibilities of remote control biochemical reactions using a nonheating low-frequency alternating magnetic field (AMF) for the controlled release of drugs are analyzed in the review. The experimental results of the AMF effects on bionanosystems containing magnetic nanoparticles, such as changing the catalytic activities of enzymes bound to magnetic nanoparticles and ‘disordering’ of the lipid bilayer in membranes, are considered.

About the authors

E. A. Zaitseva

Department of Chemistry

Author for correspondence.
Email: ezaitseva2008@gmail.com
Russian Federation, Moscow

Yu. I. Golovin

Department of Chemistry; Derzhavin Tambov State University

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow; Tambov

O. A. Kost

Department of Chemistry

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow

I. I. Nikol’skaya

Department of Chemistry

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow

K. Yu. Vlasova

Department of Chemistry

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow

L. Yu. Filatova

Department of Chemistry

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow

A. B. Belova

Department of Chemistry

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow

E. N. Efremenko

Department of Chemistry

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow

I. V. Lyagin

Department of Chemistry

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow

A. D. Aleksashkin

Department of Chemistry

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow

N. V. Nukolova

Federal Medical Research Center of Psychiatry and Addictology

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow

A. G. Majouga

Department of Chemistry; National University of Science and Technology MISiS

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow; Moscow

A. V. Kabanov

Department of Chemistry; Eshelman School of Pharmacy

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow; Chapel Hill

N. L. Klyachko

Department of Chemistry

Email: ezaitseva2008@gmail.com
Russian Federation, Moscow

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Allerton Press, Inc.